HealthLynked Corp. Announces Closing of $2,000,000 Private

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
54
HealthLynked Corp. Announces Closing of $2,000,000 Private Placement

NAPLES, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK), announced today that it has closed a $2,000,000 private placement of common stock and warrants with an institutional investor. HealthLynked Corp. issued 3,900,000 shares of common stock, pre-funded warrants to purchase 4,100,000 shares of common stock, and warrants to purchase 8,000,000 shares of common stock, plus additional warrants to purchase shares of common stock that may become exercisable following the registration of the securities issued in the private placement. The capital was raised for the purpose of technology enhancement, sales and marketing initiatives and for its planned acquisition strategy.

ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole placement agent for the offering.

George O’Leary, HealthLynked’s Chief Financial Officer, stated: “This private placement allows us to implement our acquisition strategy, which is to acquire health service businesses and offer physician owners cash, HLYK stock, and deferred compensation.  Currently we expect that acquisition targets have a practice size of at least $1 million in revenue and demonstrate at least three current consecutive years of strong profitability. We intend to focus our acquisition efforts in the state of Florida.”

The securities offered and sold by HealthLynked Corp. in the private placement were not registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the U.S. Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. HealthLynked Corp. has agreed to file a registration statement with the SEC covering the resale of the shares of common stock, including shares of common stock issuable upon exercise of the warrants, to be issued in the private placement. Any resale of HealthLynked Corp. securities under such resale registration statement will be made only by means of a prospectus.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About HealthLynked Corp.

HealthLynked Corp. provides a solution for both patient members and healthcare providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take control of their medical information. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge.

Participating healthcare providers can connect with their current and future patients through the system. Other benefits to our providers include the ability to utilize the HealthLynked marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling, and to fill last minute cancellations using our “real time appointment scheduling” mobile application. Healthcare providers pay a monthly fee to access these HealthLynked services.

For additional information about HealthLynked Corp. visit www.healthlynked.com

Forward Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to statements relating to the private placement and issuance of warrants; the acquisition strategy; the expected criteria for acquisition target and the use of proceeds from the private placement.  Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Forward looking statements are subject to risks and uncertainties applicable to us and our operations, and some of these risks are described in our most recent Annual Reports on Form 10-K or Quarterly Reports on Form 10-Q and in other filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections of these reports and filings. These reports are available to the public at www.sec.gov.

Company Contact:

George O’Leary
Chief Financial Officer
goleary@healthlynked.com

Investor Relations contact:

Jim Hock
Hanover International Inc.
Investor Relations
jh@hanoverinternationalinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 3

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 3

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 3

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 7

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 5

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 4

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 4

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 4

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 8

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 6

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading

Top 5 Most Recently Viewed Articles

The Surge in Human-Machine Interface Market Growth Forecast

Updated Category News Views 102

Overview of the Human-Machine Interface Market The global human-machine interface (HMI) market is currently valued at about USD 4.07 billion and is expected to grow significantly, possibly reaching USD 10.64 billion within the next decade. This remarkable growth reflects a compound annual growth rate (CAGR) of 10.1%. The importance of Human-Machine Interfaces stems from...

Continue Reading
Mattel, Inc. CFO Anthony DiSilvestro Sets Retirement Plans

Updated Category News Views 248

Leadership Transition at Mattel, Inc. Mattel, Inc. (NASDAQ: MAT), the recognized leader in toy production, has announced a significant transition within its executive team as its Chief Financial Officer, Anthony DiSilvestro, has plans to retire. The planned retirement is set for May, with the company actively searching for DiSilvestro's successor. The transition strategy...

Continue Reading
Exciting Progress in B-cell Lymphoma Treatments with REC-3565

Updated Category News Views 134

Groundbreaking Steps in Cancer Treatment with REC-3565 Recursion, a trailblazer in the TechBio realm, has announced an exciting new development: the first patient has been dosed in a Phase 1 clinical study of REC-3565, a selective MALT1 inhibitor aimed at treating relapsed or refractory B-cell lymphomas. This endeavor signifies a pivotal moment in the realm of...

Continue Reading
Understanding Dow Inc.'s Legal Challenges and Stock Performance

Updated Category News Views 361

Legal Challenges Faced by Dow Inc. As one of the leading companies in materials science solutions, Dow Inc. (NYSE: DOW) is currently facing significant legal challenges that are affecting its investors. The ongoing situation involves a class action lawsuit aimed at protecting shareholders who bought Dow securities between late January and late July. The legal proceedings...

Continue Reading
Palvella Therapeutics Welcomes David W. Osborne as Chief Innovator

Updated Category News Views 129

Palvella Therapeutics Appoints New Chief Innovation Officer Palvella Therapeutics, Inc. has recently announced the appointment of Dr. David W. Osborne as their Chief Innovation Officer. With over 25 years of exceptional experience in the pharmaceutical industry, Dr. Osborne brings a wealth of knowledge in developing innovative therapies for serious, rare genetic skin...

Continue Reading